BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 26226569)

  • 1. Increasing the Impact of Randomized, Controlled Trials in Gastrointestinal Endoscopy.
    Elmunzer BJ
    Gastroenterology; 2015 Sep; 149(3):521-5. PubMed ID: 26226569
    [No Abstract]   [Full Text] [Related]  

  • 2. The evolution of the randomized controlled trial and its role in evidence-based decision making.
    Devereaux PJ; Yusuf S
    J Intern Med; 2003 Aug; 254(2):105-13. PubMed ID: 12859691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, controlled trials: Gold or bronze?
    Cheng Hy
    J Am Med Dir Assoc; 2006 Nov; 7(9):611-2. PubMed ID: 17095430
    [No Abstract]   [Full Text] [Related]  

  • 4. Reinventing the wheel? Or the emperor's new clothes.
    Oberbaum M; Vithoulkas G; van Haselen R; Singer S
    J Altern Complement Med; 2003 Oct; 9(5):613-5. PubMed ID: 14629837
    [No Abstract]   [Full Text] [Related]  

  • 5. How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump?
    Montori VM; Busse JW; Permanyer-Miralda G; Ferreira I; Guyatt GH
    ACP J Club; 2005; 143(3):A8. PubMed ID: 16262212
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized clinical trials: the meeting place of medical practice and clinical research.
    Hughes EG
    Semin Reprod Med; 2003 Feb; 21(1):55-64. PubMed ID: 12806560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of evidence reviews: three years of progress.
    Ashman EJ; Gronseth GS
    Neurology; 2012 Jul; 79(1):13-4. PubMed ID: 22722620
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized controlled trials, evidence-based medicine and India.
    Jacob KS
    Natl Med J India; 2012; 25(1):1-4. PubMed ID: 22680311
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.
    Booth CM
    Clin Cancer Res; 2010 Dec; 16(24):5963-71. PubMed ID: 21169249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of control group in randomised trials of cancer medicine: are we testing trivialities?
    Tao D; Prasad V
    Lancet Oncol; 2018 Sep; 19(9):1150-1152. PubMed ID: 30191836
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of reporting in randomized trials.
    Sataloff RT
    Ear Nose Throat J; 2010 Apr; 89(4):150. PubMed ID: 20397138
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence-based recommendations for spine surgery.
    Fisher CG; Vaccaro AR; Patel AA; Prasad SK; Chi J; Mulpuri K; Thomas KC; Whang PG
    Spine (Phila Pa 1976); 2015 Mar; 40(5):E309-16. PubMed ID: 25901985
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quality assessment of therapeutic clinical trials].
    Selbmann HK; Meisner C
    Internist (Berl); 2000 Apr; 41(4):344-8. PubMed ID: 10798182
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodological changes in the evaluation of complementary and alternative medicine: issues raised by Sherman et al. and Hawk et al.
    Redwood D
    J Altern Complement Med; 2002 Feb; 8(1):5-6. PubMed ID: 11890434
    [No Abstract]   [Full Text] [Related]  

  • 16. [From research to patient care. Evidence based medicine and individualized therapy: a contradiction?].
    Ertel G
    Med Klin (Munich); 2007 Oct; 102(10):869-71. PubMed ID: 17985485
    [No Abstract]   [Full Text] [Related]  

  • 17. The quality of reports of randomized trials in multiple sclerosis: a review.
    Signori A; Baccino A; Sormani MP
    Mult Scler; 2012 Jun; 18(6):776-81. PubMed ID: 22495947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.
    D'Haens G; Feagan B; Colombel JF; Sandborn WJ; Reinisch W; Rutgeerts P; Carbonnel F; Mary JY; Danese S; Fedorak RN; Hanauer S; LĂ©mann M;
    Gastroenterology; 2012 Dec; 143(6):1461-9. PubMed ID: 23000597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating standardised reporting guidelines in clinical trials of artificial intelligence in gastrointestinal endoscopy.
    Bilal M; Brown JRG; Berzin TM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):962-964. PubMed ID: 32918871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.